scispace - formally typeset
T

Tamara Shiner

Researcher at Tel Aviv Sourasky Medical Center

Publications -  33
Citations -  1302

Tamara Shiner is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Dementia with Lewy bodies & Parkinson's disease. The author has an hindex of 13, co-authored 27 publications receiving 1053 citations. Previous affiliations of Tamara Shiner include Tel Aviv University & Wellcome Trust Centre for Neuroimaging.

Papers
More filters
Journal ArticleDOI

Dopamine, affordance and active inference.

TL;DR: This paper focuses on the consequences of changing tonic levels of dopamine firing using simulations of cued sequential movements and uses these simulations to demonstrate how a single functional role for dopamine at the synaptic level can manifest in different ways at the behavioural level.
Journal ArticleDOI

Dopamine, Time, and Impulsivity in Humans

TL;DR: It is demonstrated that pharmacologically enhancing dopamine activity increases impulsivity by enhancing the diminutive influence of increasing delay on reward value and its corresponding neural representation in the striatum, which leads to a state of excessive discounting of temporally distant, relative to sooner, rewards.
Journal ArticleDOI

Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.

TL;DR: It is found that dopamine modulation of nucleus accumbens and ventromedial prefrontal cortex exerts a specific effect on choice behaviour distinct from pure learning, and that dopamine plays a key role in performance that may be distinct from its role in learning.
Journal ArticleDOI

Dopamine Enhances Expectation of Pleasure in Humans

TL;DR: It is shown that administration of a drug that enhances dopaminergic function during the imaginative construction of positive future life events subsequently enhances estimates of the hedonic pleasure to be derived from these same events.
Journal ArticleDOI

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.

TL;DR: Motor, cognitive, olfactory and psychiatric symptoms are more severe in sGBA and GD-PD compared to mGBAand iPD, reinforcing the notion that the severity of the PD phenotype is related to the severityof the mutation in the GBA gene.